Kristen Fortney, co-founder and CEO of BioAge Labs
December 3, 2020 10:36 AM ESTUpdated 11:11 AM
Financing
R&D

A high-pro­file ‘an­gel’ joins the Sil­i­con Val­ley crew back­ing an an­ti-ag­ing up­start with an eye on PhII

Max Gelman

Senior Editor

Sil­i­con Val­ley’s mis­sion to con­quer ag­ing rages on, as two high-pro­file VCs are lead­ing a new Se­ries C in the field.

BioAge Labs, a Rich­mond …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times